Schedule of Warrants Activity (Details) |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| Warrants | |
| Number of warrants, outstanding | shares | 960,847 |
| Weighted average exercise price, outstanding | $ / shares | $ 20.23 |
| Number of warrants, granted | shares | 2,043,492 |
| Weighted average exercise price, granted | $ / shares | $ 7.48 |
| Number of warrants, exercised | shares | (952,569) |
| Weighted average exercise price, exercised | $ / shares | $ 9.08 |
| Number of warrants, canceled | shares | |
| Weighted average exercise price, canceled | $ / shares | |
| Number of warrants, outstanding | shares | 2,051,770 |
| Weighted average exercise price, outstanding | $ / shares | $ 12.48 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price warrants. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price of warrants exercised. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options grants weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share basedPayment award non options canceled in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|